Soligenix
SNGX
#10223
Rank
A$24.58 M
Marketcap
A$2.44
Share price
-1.23%
Change (1 day)
-50.88%
Change (1 year)

Soligenix (SNGX) - Cash on Hand

Cash on Hand as of September 2025 : A$15.93 Million

According to Soligenix's latest financial reports the company has A$15.93 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Soligenix - Cash on Hand chart (from 1998 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$12.57 M1.41%
2023-12-31A$12.39 M-36.85%
2022-12-31A$19.63 M-45.35%
2021-12-31A$35.92 M47.9%
2020-12-31A$24.28 M213.72%
2019-12-31A$7.74 M-39.29%
2018-12-31A$12.75 M27.48%
2017-12-31A$10 M-17.81%
2016-12-31A$12.17 M80.14%
2015-12-31A$6.75 M0.07%
2014-12-31A$6.75 M2.83%
2013-12-31A$6.56 M103.28%
2012-12-31A$3.22 M-44.78%
2011-12-31A$5.84 M-20.28%
2010-12-31A$7.33 M-14.33%
2009-12-31A$8.56 M309.44%
2008-12-31A$2.09 M-17.64%
2007-12-31A$2.53 M1573.24%
2006-12-31A$0.15 M-86.49%
2005-12-31A$1.12 M-62.74%
2004-12-31A$3.01 M-45.6%
2003-12-31A$5.53 M-24.74%
2002-12-31A$7.36 M-62.21%
2001-12-31A$19.48 M-15.21%
2000-12-31A$22.97 M76.71%
1999-12-31A$13 M-47.28%
1998-12-31A$24.66 M2.34%
1997-12-31A$24.09 M
1996-01-31A$1.37 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.37 B 2,232.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$15.82 B 99,202.63%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
A$22.68 B 142,261.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$28.09 B 176,256.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
A$1.54 M-90.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$24.8 M 55.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.33 B 20,830.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel